Impact of Drug Repurposing on SARS-Cov-2 Main Protease

被引：0
|
作者：
Umar Ndagi
Maryam Abdullahi
Asmau N. Hamza
Mohd G. Magaji
Ndumiso N. Mhlongo
Makun Babazhitsu
Hussaini Majiya
Hussaini Anthony Makun
Monsurat M. Lawal
机构：
[1] Africa Centre of Excellence for Mycotoxin and Food Safety,
[2] Federal University of Technology,undefined
[3] Faculty of Pharmaceutical Sciences,undefined
[4] Ahmadu Bello University,undefined
[5] Zaria,undefined
[6] Department of Medical Biochemistry,undefined
[7] School of Laboratory Medicine and Medical Sciences,undefined
[8] University of KwaZulu-Natal,undefined
[9] Department of Medical Microbiology and Parasitology,undefined
[10] Faculty of Basic Clinical Sciences,undefined
[11] College of Health Sciences,undefined
[12] Usman Danfodio University,undefined
[13] Department of Microbiology,undefined
[14] Ibrahim Badamasi Babangida University,undefined
[15] Lapai,undefined
来源：
Russian Journal of Physical Chemistry A | 2022年 / 96卷
关键词：
SARS-CoV-2 main protease (M; ); remdesivir; β-D-N; -hydroxycytidine (NHC); hydroxychloroquine (HCQ); molecular dynamics (MD) simulation; anti-covid-19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3311 / 3330
页数：19
相关论文
共 50 条
  • [1] Impact of Drug Repurposing on SARS-Cov-2 Main Protease
    Ndagi, Umar
    Abdullahi, Maryam
    Hamza, Asmau N. N.
    Magaji, Mohd G. G.
    Mhlongo, Ndumiso N. N.
    Babazhitsu, Makun
    Majiya, Hussaini
    Makun, Hussaini Anthony
    Lawal, Monsurat M. M.
    [J]. RUSSIAN JOURNAL OF PHYSICAL CHEMISTRY A, 2022, 96 (14) : 3311 - 3330
  • [2] Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease
    Sarkar, Arighna
    Mandal, Kalyaneswar
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (44) : 23492 - 23494
  • [3] Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
    Baby, Krishnaprasad
    Maity, Swastika
    Mehta, Chetan H.
    Suresh, Akhil
    Nayak, Usha Y.
    Nayak, Yogendra
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (01) : 38 - 47
  • [4] Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors
    Fiorucci, Diego
    Milletti, Eva
    Orofino, Francesco
    Brizzi, Antonella
    Mugnaini, Claudia
    Corelli, Federico
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (16): : 6242 - 6248
  • [5] In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro SARS-CoV-2
    Baby, Krishnaprasad
    Maity, Swastika
    Mehta, Chetan
    Suresh, Akhil
    Nayak, Usha Y.
    Nayak, Yogendra
    [J]. PHARMACEUTICAL SCIENCES, 2020, 26 : S52 - S62
  • [6] Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a NovelIn SilicoMethod
    Sencanski, Milan
    Perovic, Vladimir
    Pajovic, Snezana B.
    Adzic, Miroslav
    Paessler, Slobodan
    Glisic, Sanja
    [J]. MOLECULES, 2020, 25 (17):
  • [7] Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
    Pinzi, Luca
    Tinivella, Annachiara
    Caporuscio, Fabiana
    Rastelli, Giulio
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
    Sharma, Shilpa
    Deep, Shashank
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07): : 3003 - 3010
  • [9] Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
    Omer, Samia E.
    Ibrahim, Tawasol M.
    Krar, Omer A.
    Ali, Amna M.
    Makki, Alaa A.
    Ibraheem, Walaa
    Alzain, Abdulrahim A.
    [J]. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 29
  • [10] Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2
    Silva, Jose Rogerio A.
    Kruger, Hendrik G.
    Molfetta, Fabio A.
    [J]. RSC ADVANCES, 2021, 11 (38) : 23450 - 23458
12345